Spruce Biosciences Inc (SPRB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1298 -0.0101 (-7.22%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.0850 -0.0448 (-34.51%) 19:59 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -53,036 | -47,919 | -46,180 | -42,292 | -29,539 |
Depreciation Amortization | 46 | -566 | 90 | 189 | 36 |
Accounts payable and accrued liabilities | -2,037 | 1,906 | -1,397 | -805 | N/A |
Other Working Capital | -8,571 | 10,356 | 1,132 | 1,955 | 1,163 |
Other Operating Activity | 7,634 | 2,948 | 4,672 | 5,076 | 821 |
Operating Cash Flow | $-55,964 | $-33,275 | $-41,683 | $-35,877 | $-27,519 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | 55,784 | 23,700 | -79,075 | N/A |
PPE Investments | N/A | -7 | -8 | -93 | -74 |
Investing Cash Flow | $N/A | $55,777 | $23,692 | $-79,168 | $-74 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | 4,990 | N/A |
Debt Repayment | -1,622 | -1,622 | N/A | -4,770 | 0 |
Common Stock Issued | 246 | 53,794 | 78 | 462 | 93,402 |
Other Financing Activity | -246 | -3,032 | -319 | -39 | 87,633 |
Financing Cash Flow | $-1,622 | $49,140 | $-241 | $643 | $181,035 |
Beginning Cash Position | 96,374 | 24,732 | 42,964 | 157,366 | 3,924 |
End Cash Position | 38,788 | 96,374 | 24,732 | 42,964 | 157,366 |
Net Cash Flow | $-57,586 | $71,642 | $-18,232 | $-114,402 | $153,442 |
Free Cash Flow | |||||
Operating Cash Flow | -55,964 | -33,275 | -41,683 | -35,877 | -27,519 |
Capital Expenditure | N/A | -7 | -8 | -93 | -74 |
Free Cash Flow | -55,964 | -33,282 | -41,691 | -35,970 | -27,593 |